CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered in the neoadjuvant setting followed by r...
Phase 1
Columbus, Ohio, United States and 5 other locations
Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...
Phase 1
Columbus, Ohio, United States and 17 other locations
The objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to su...
Phase 1
Columbus, Ohio, United States and 3 other locations
practice to see if FK-PC101 works to prevent or delay the return of prostate cancer following surgery to remove the prostate...
Phase 2
Gahanna, Ohio, United States and 2 other locations
Researchers are looking for a better way to treat men who have biochemically recurrent hormone-naïve prostate cancer.Hormone-naïve ...
Phase 2
Gahanna, Ohio, United States and 4 other locations
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Gahanna, Ohio, United States and 31 other locations
This phase II trial compares the effect of relugolix to leuprolide on cardiac function and performance in patients with prostate cancer...
Phase 2
Columbus, Ohio, United States
Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...
Phase 3
Gahanna, Ohio, United States and 51 other locations
compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate...
Phase 3
Columbus, Ohio, United States and 236 other locations
cemiplimab, or in combination with REGN5678. REGN4336, cemiplimab and REGN5678 are a type of treatment for cancer called immunotherapy,and ...
Phase 1, Phase 2
Columbus, Ohio, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal